title: Development of quality indicators for monitoring of the disease course in rheumatoid arthritis.
abstract: OBJECTIVE
  To suppress rheumatoid arthritis (RA) patients' disease activity, it should be periodically measured and patients should be treated on the basis of the disease activity outcomes. Insight into the actual care, by using quality indicators, is the first step in achieving optimal care. The objective of this study was to develop a set of quality indicators to evaluate RA disease course monitoring of rheumatologists in daily clinical practice.
  
  
  METHODS
  A RAND-modified Delphi method in a five-step procedure was applied: a literature search for quality indicators and recommendations about disease course monitoring; a first questionnaire round; a consensus meeting; a second questionnaire round and drawing up the final set.
  
  
  RESULTS
  The systematic procedure resulted in the development of 18 quality indicators: 10 process, five structure and three outcome indicators that describe seven domains of disease course monitoring: schedule follow-up visits; measure disease activity; functional impairment; structural damage; change medication; preconditions for measuring disease activity and outcome measures in terms of disease activity.
  
  
  CONCLUSIONS
  This quality indicator set can be used to assess the quality of disease course monitoring of rheumatologists in daily clinical practice, and to determine for which aspects of disease course monitoring rheumatologists perform well, or where there is room for improvement. This information can be used to improve the quality of disease course monitoring.
authors.affiliation: Department of Rheumatology (470), Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands. L.vanhulst@reuma.umcn.nl
authors.forename: L T C
authors.initials: LT
authors.lastname: van Hulst
authors.forename: J
authors.initials: J
authors.lastname: Fransen
authors.forename: A A
authors.initials: AA
authors.lastname: den Broeder
authors.forename: R
authors.initials: R
authors.lastname: Grol
authors.forename: P L C M
authors.initials: PL
authors.lastname: van Riel
authors.forename: M E J L
authors.initials: ME
authors.lastname: Hulscher
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D003697:Delphi Technique; D016903:Drug Monitoring / Q000592:standards; D019317:Evidence-Based Medicine / Q000379:methods; D006302:Health Services Research / Q000379:methods; D006801:Humans; D009426:Netherlands; D019984:Quality Indicators, Health Care; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents